Zai Lab Stock Performance
| ZLAB Stock | USD 37.17 0.60 1.59% |
On a scale of 0 to 100, Zai Lab holds a performance score of 5. The firm maintains a market beta of 1.28, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Zai Lab will likely underperform. Please check Zai Lab's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Zai Lab's historical returns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Zai Lab are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zai Lab sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.59) | Five Day Return 7.43 | Year To Date Return 49.82 | Ten Year Return 33.08 | All Time Return 33.08 |
1 | Disposition of 4352 shares by Joshua Smiley of Zai Lab at 16.673 subject to Rule 16b-3 | 05/02/2025 |
2 | Disposition of 50000 shares by Ying Du of Zai Lab at 0.6 subject to Rule 16b-3 | 05/12/2025 |
3 | Disposition of 46389 shares by Ying Du of Zai Lab at 0.6 subject to Rule 16b-3 | 05/14/2025 |
4 | Disposition of 32062 shares by Joshua Smiley of Zai Lab subject to Rule 16b-3 | 05/23/2025 |
5 | Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust ... | 06/02/2025 |
6 | Acquisition by Leung Nisa of 10831 shares of Zai Lab subject to Rule 16b-3 | 06/18/2025 |
7 | Zai Lab Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis | 06/20/2025 |
8 | Insider Sell William Lis Sells 13,814 Shares of Zai Lab Ltd | 06/23/2025 |
9 | Disposition of 6250 shares by Yajing Chen of Zai Lab subject to Rule 16b-3 | 06/25/2025 |
10 | Disposition of 2675 shares by Yajing Chen of Zai Lab at 36.132 subject to Rule 16b-3 | 06/26/2025 |
11 | Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b Positive First-Line Gastric Cancer | 06/30/2025 |
12 | Disposition of 18000 shares by Ying Du of Zai Lab subject to Rule 16b-3 | 07/01/2025 |
13 | Disposition of 7072 shares by Ying Du of Zai Lab at 35.23 subject to Rule 16b-3 | 07/02/2025 |
14 | Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 | 07/10/2025 |
15 | What drives Zai Lab Limited Depositary Receipt stock price - Accelerated wealth building - Autocar Professional | 07/21/2025 |
16 | Zai Lab Limiteds large institutional owners must be happy as stock continues to impress, up 4.9 percent over the past week | 07/25/2025 |
| Begin Period Cash Flow | 791.3 M | |
| Total Cashflows From Investing Activities | -375.2 M |
Zai Lab Relative Risk vs. Return Landscape
If you would invest 3,243 in Zai Lab on April 27, 2025 and sell it today you would earn a total of 474.00 from holding Zai Lab or generate 14.62% return on investment over 90 days. Zai Lab is currently generating 0.2903% in daily expected returns and assumes 3.9073% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Zai, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zai Lab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zai Lab's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zai Lab, and traders can use it to determine the average amount a Zai Lab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0743
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ZLAB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.91 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Zai Lab is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zai Lab by adding it to a well-diversified portfolio.
Zai Lab Fundamentals Growth
Zai Stock prices reflect investors' perceptions of the future prospects and financial health of Zai Lab, and Zai Lab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zai Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.60) % | ||||
| Operating Margin | (0.53) % | ||||
| Current Valuation | 3.64 B | ||||
| Shares Outstanding | 110.39 M | ||||
| Price To Book | 5.14 X | ||||
| Price To Sales | 9.89 X | ||||
| Revenue | 398.99 M | ||||
| Gross Profit | 24.85 M | ||||
| EBITDA | (234.57 M) | ||||
| Net Income | (257.1 M) | ||||
| Cash And Equivalents | 1.26 B | ||||
| Cash Per Share | 13.10 X | ||||
| Total Debt | 153.47 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 7.91 X | ||||
| Book Value Per Share | 7.48 X | ||||
| Cash Flow From Operations | (214.87 M) | ||||
| Earnings Per Share | (2.50) X | ||||
| Market Capitalization | 4.14 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (2.45 B) | ||||
| Working Capital | 751.1 M | ||||
About Zai Lab Performance
By analyzing Zai Lab's fundamental ratios, stakeholders can gain valuable insights into Zai Lab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zai Lab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zai Lab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 98.43 | 93.51 | |
| Return On Tangible Assets | (0.23) | (0.24) | |
| Return On Capital Employed | (0.32) | (0.33) | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | (0.31) | (0.32) |
Things to note about Zai Lab performance evaluation
Checking the ongoing alerts about Zai Lab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zai Lab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zai Lab had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 398.99 M. Net Loss for the year was (257.1 M) with profit before overhead, payroll, taxes, and interest of 24.85 M. | |
| Zai Lab currently holds about 1.26 B in cash with (214.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.1. | |
| Latest headline from simplywall.st: Zai Lab Limiteds large institutional owners must be happy as stock continues to impress, up 4.9 percent over the past week |
- Analyzing Zai Lab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zai Lab's stock is overvalued or undervalued compared to its peers.
- Examining Zai Lab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zai Lab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zai Lab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zai Lab's stock. These opinions can provide insight into Zai Lab's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |